Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
An overview of which total market fund performed best in 2024, with notes on expense, tracking error, and performance drivers.
28,518 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
NVDY is pursuing income by selling Nvidia’s strongest move days, financing a roughly 60% distribution. The strategy b...
If you're wondering should bitcoin while it's under 69K, you’re not alone. This guide breaks down the risks, the math...
A big move after a big gain can signal strategy, not fear. Discover why a fund sold million as a stock jumped 40% and...
MRCC unveiled a $0.75 special distribution tied to reserve funds as it merges with HRZN. Despite the payout, investor...
As markets wobble in June 2026, investors weigh the true liquidity of stocks. This report explains why stocks are sti...
Bitcoin on-chain signals from Glassnode show a shift toward loss-dominant selling, with key metrics dipping below bea...
Retail traders are shifting capital from crypto to stocks, marking a sharp pivot after Bitcoin's peak. January 2026 s...
Trading activity in the largest non-stablecoin crypto assets cooled to two-year lows as investors sit on the sideline...
ADA sinks toward its latest lows as the broader crypto sell-off deepens. With Hoskinson’s cautions and liquidity fadi...
A year after XRP surged to $3.65, ripple (xrp) peaked $3.65 remains a milestone. Today, the token is far lower as reg...
AMH reports solid 2025 results as it navigates an overbuilt rental market, with revenue gains driven by disciplined a...